REPOSITORY ID,REPOSITORY LINK,SAMPLE NUMBER,STUDY TITLE,STUDY LINK,ASSAY TYPE,TECHNOLOGY,COUNTRY,DISEASE,DOID,STUDY DESIGN,BODY SITE,PLATFORM,PARTICIPANT FEATURES,AVERAGE SPOTLENGTH,RUN ID,Sample ID,Sample Name,COLLECTION DATE,LIBRARY LAYOUT,LAT LON,SAMPLE TYPE,ETHNICITY,ELO,URBANZATION,REGION,CITYVILLAGE,TARGET AMPLICON,DIET
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351393,ERS3490587,SAMEA5686603 ERS3490587,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351394,ERS3490588,SAMEA5686604 ERS3490588,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351395,ERS3490589,SAMEA5686605 ERS3490589,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351396,ERS3490590,SAMEA5686606 ERS3490590,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351397,ERS3490591,SAMEA5686607 ERS3490591,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351398,ERS3490592,SAMEA5686608 ERS3490592,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351399,ERS3490593,SAMEA5686609 ERS3490593,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351400,ERS3490594,SAMEA5686610 ERS3490594,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351401,ERS3490595,SAMEA5686611 ERS3490595,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351402,ERS3490596,SAMEA5686612 ERS3490596,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351403,ERS3490597,SAMEA5686613 ERS3490597,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351404,ERS3490598,SAMEA5686614 ERS3490598,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351405,ERS3490599,SAMEA5686615 ERS3490599,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351406,ERS3490600,SAMEA5686616 ERS3490600,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351407,ERS3490601,SAMEA5686617 ERS3490601,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351408,ERS3490602,SAMEA5686618 ERS3490602,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351409,ERS3490603,SAMEA5686619 ERS3490603,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351410,ERS3490604,SAMEA5686620 ERS3490604,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351411,ERS3490605,SAMEA5686621 ERS3490605,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351412,ERS3490606,SAMEA5686622 ERS3490606,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351413,ERS3490607,SAMEA5686623 ERS3490607,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351414,ERS3490608,SAMEA5686624 ERS3490608,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351415,ERS3490609,SAMEA5686625 ERS3490609,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351416,ERS3490610,SAMEA5686626 ERS3490610,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351417,ERS3490611,SAMEA5686627 ERS3490611,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351418,ERS3490612,SAMEA5686628 ERS3490612,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351419,ERS3490613,SAMEA5686629 ERS3490613,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351420,ERS3490614,SAMEA5686630 ERS3490614,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351421,ERS3490615,SAMEA5686631 ERS3490615,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351422,ERS3490616,SAMEA5686632 ERS3490616,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351423,ERS3490617,SAMEA5686633 ERS3490617,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351424,ERS3490618,SAMEA5686634 ERS3490618,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351425,ERS3490619,SAMEA5686635 ERS3490619,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351426,ERS3490620,SAMEA5686636 ERS3490620,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351427,ERS3490621,SAMEA5686637 ERS3490621,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351428,ERS3490622,SAMEA5686638 ERS3490622,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351429,ERS3490623,SAMEA5686639 ERS3490623,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351430,ERS3490624,SAMEA5686640 ERS3490624,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351431,ERS3490625,SAMEA5686641 ERS3490625,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351432,ERS3490626,SAMEA5686642 ERS3490626,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351433,ERS3490627,SAMEA5686643 ERS3490627,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351434,ERS3490628,SAMEA5686644 ERS3490628,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351435,ERS3490629,SAMEA5686645 ERS3490629,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351436,ERS3490630,SAMEA5686646 ERS3490630,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351437,ERS3490631,SAMEA5686647 ERS3490631,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351438,ERS3490632,SAMEA5686648 ERS3490632,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351439,ERS3490633,SAMEA5686649 ERS3490633,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351440,ERS3490634,SAMEA5686650 ERS3490634,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351441,ERS3490635,SAMEA5686651 ERS3490635,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351442,ERS3490636,SAMEA5686652 ERS3490636,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351443,ERS3490637,SAMEA5686653 ERS3490637,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351444,ERS3490638,SAMEA5686654 ERS3490638,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351445,ERS3490639,SAMEA5686655 ERS3490639,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351446,ERS3490640,SAMEA5686656 ERS3490640,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351447,ERS3490641,SAMEA5686657 ERS3490641,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351448,ERS3490642,SAMEA5686658 ERS3490642,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351449,ERS3490643,SAMEA5686659 ERS3490643,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351450,ERS3490644,SAMEA5686660 ERS3490644,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351451,ERS3490645,SAMEA5686661 ERS3490645,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351452,ERS3490646,SAMEA5686662 ERS3490646,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351453,ERS3490647,SAMEA5686663 ERS3490647,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351454,ERS3490648,SAMEA5686664 ERS3490648,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351455,ERS3490649,SAMEA5686665 ERS3490649,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351456,ERS3490650,SAMEA5686666 ERS3490650,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351457,ERS3490651,SAMEA5686667 ERS3490651,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351458,ERS3490652,SAMEA5686668 ERS3490652,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351459,ERS3490653,SAMEA5686669 ERS3490653,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351460,ERS3490654,SAMEA5686670 ERS3490654,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351461,ERS3490655,SAMEA5686671 ERS3490655,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351462,ERS3490656,SAMEA5686672 ERS3490656,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351463,ERS3490657,SAMEA5686673 ERS3490657,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351464,ERS3490658,SAMEA5686674 ERS3490658,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351465,ERS3490659,SAMEA5686675 ERS3490659,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351466,ERS3490660,SAMEA5686676 ERS3490660,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351467,ERS3490661,SAMEA5686677 ERS3490661,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351468,ERS3490662,SAMEA5686678 ERS3490662,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351469,ERS3490663,SAMEA5686679 ERS3490663,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351470,ERS3490664,SAMEA5686680 ERS3490664,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351471,ERS3490665,SAMEA5686681 ERS3490665,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351472,ERS3490666,SAMEA5686682 ERS3490666,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351473,ERS3490667,SAMEA5686683 ERS3490667,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351474,ERS3490668,SAMEA5686684 ERS3490668,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351475,ERS3490669,SAMEA5686685 ERS3490669,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351476,ERS3490670,SAMEA5686686 ERS3490670,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351477,ERS3490671,SAMEA5686687 ERS3490671,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351478,ERS3490672,SAMEA5686688 ERS3490672,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351479,ERS3490673,SAMEA5686689 ERS3490673,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351480,ERS3490674,SAMEA5686690 ERS3490674,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351481,ERS3490675,SAMEA5686691 ERS3490675,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351482,ERS3490676,SAMEA5686692 ERS3490676,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351483,ERS3490677,SAMEA5686693 ERS3490677,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351484,ERS3490678,SAMEA5686694 ERS3490678,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351485,ERS3490679,SAMEA5686695 ERS3490679,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351486,ERS3490680,SAMEA5686696 ERS3490680,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351487,ERS3490681,SAMEA5686697 ERS3490681,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351488,ERS3490682,SAMEA5686698 ERS3490682,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351489,ERS3490683,SAMEA5686699 ERS3490683,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351490,ERS3490684,SAMEA5686700 ERS3490684,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351491,ERS3490685,SAMEA5686701 ERS3490685,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351492,ERS3490686,SAMEA5686702 ERS3490686,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351493,ERS3490687,SAMEA5686703 ERS3490687,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351494,ERS3490688,SAMEA5686704 ERS3490688,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351495,ERS3490689,SAMEA5686705 ERS3490689,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351496,ERS3490690,SAMEA5686706 ERS3490690,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351497,ERS3490691,SAMEA5686707 ERS3490691,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351498,ERS3490692,SAMEA5686708 ERS3490692,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351499,ERS3490693,SAMEA5686709 ERS3490693,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351500,ERS3490694,SAMEA5686710 ERS3490694,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351501,ERS3490695,SAMEA5686711 ERS3490695,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351502,ERS3490696,SAMEA5686712 ERS3490696,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351503,ERS3490697,SAMEA5686713 ERS3490697,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351504,ERS3490698,SAMEA5686714 ERS3490698,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351505,ERS3490699,SAMEA5686715 ERS3490699,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351506,ERS3490700,SAMEA5686716 ERS3490700,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351507,ERS3490701,SAMEA5686717 ERS3490701,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351508,ERS3490702,SAMEA5686718 ERS3490702,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351509,ERS3490703,SAMEA5686719 ERS3490703,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351510,ERS3490704,SAMEA5686720 ERS3490704,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351511,ERS3490705,SAMEA5686721 ERS3490705,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351512,ERS3490706,SAMEA5686722 ERS3490706,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351513,ERS3490707,SAMEA5686723 ERS3490707,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351514,ERS3490708,SAMEA5686724 ERS3490708,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351515,ERS3490709,SAMEA5686725 ERS3490709,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351516,ERS3490710,SAMEA5686726 ERS3490710,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351517,ERS3490711,SAMEA5686727 ERS3490711,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351518,ERS3490712,SAMEA5686728 ERS3490712,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351519,ERS3490713,SAMEA5686729 ERS3490713,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351520,ERS3490714,SAMEA5686730 ERS3490714,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351521,ERS3490715,SAMEA5686731 ERS3490715,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351522,ERS3490716,SAMEA5686732 ERS3490716,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351523,ERS3490717,SAMEA5686733 ERS3490717,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351524,ERS3490718,SAMEA5686734 ERS3490718,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351525,ERS3490719,SAMEA5686735 ERS3490719,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351526,ERS3490720,SAMEA5686736 ERS3490720,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351527,ERS3490721,SAMEA5686737 ERS3490721,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351528,ERS3490722,SAMEA5686738 ERS3490722,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351529,ERS3490723,SAMEA5686739 ERS3490723,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351530,ERS3490724,SAMEA5686740 ERS3490724,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351531,ERS3490725,SAMEA5686741 ERS3490725,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351532,ERS3490726,SAMEA5686742 ERS3490726,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351533,ERS3490727,SAMEA5686743 ERS3490727,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351534,ERS3490728,SAMEA5686744 ERS3490728,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351535,ERS3490729,SAMEA5686745 ERS3490729,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351536,ERS3490730,SAMEA5686746 ERS3490730,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351537,ERS3490731,SAMEA5686747 ERS3490731,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351538,ERS3490732,SAMEA5686748 ERS3490732,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351539,ERS3490733,SAMEA5686749 ERS3490733,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351540,ERS3490734,SAMEA5686750 ERS3490734,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351541,ERS3490735,SAMEA5686751 ERS3490735,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351542,ERS3490736,SAMEA5686752 ERS3490736,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351543,ERS3490737,SAMEA5686753 ERS3490737,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351544,ERS3490738,SAMEA5686754 ERS3490738,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351545,ERS3490739,SAMEA5686755 ERS3490739,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351546,ERS3490740,SAMEA5686756 ERS3490740,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351547,ERS3490741,SAMEA5686757 ERS3490741,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351548,ERS3490742,SAMEA5686758 ERS3490742,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351549,ERS3490743,SAMEA5686759 ERS3490743,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351550,ERS3490744,SAMEA5686760 ERS3490744,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351551,ERS3490745,SAMEA5686761 ERS3490745,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351552,ERS3490746,SAMEA5686762 ERS3490746,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351553,ERS3490747,SAMEA5686763 ERS3490747,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351554,ERS3490748,SAMEA5686764 ERS3490748,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351555,ERS3490749,SAMEA5686765 ERS3490749,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351556,ERS3490750,SAMEA5686766 ERS3490750,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351557,ERS3490751,SAMEA5686767 ERS3490751,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351558,ERS3490752,SAMEA5686768 ERS3490752,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351559,ERS3490753,SAMEA5686769 ERS3490753,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351560,ERS3490754,SAMEA5686770 ERS3490754,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351561,ERS3490755,SAMEA5686771 ERS3490755,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351562,ERS3490756,SAMEA5686772 ERS3490756,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351563,ERS3490757,SAMEA5686773 ERS3490757,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351564,ERS3490758,SAMEA5686774 ERS3490758,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351565,ERS3490759,SAMEA5686775 ERS3490759,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351566,ERS3490760,SAMEA5686776 ERS3490760,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351567,ERS3490761,SAMEA5686777 ERS3490761,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351568,ERS3490762,SAMEA5686778 ERS3490762,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351569,ERS3490763,SAMEA5686779 ERS3490763,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351570,ERS3490764,SAMEA5686780 ERS3490764,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351571,ERS3490765,SAMEA5686781 ERS3490765,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351572,ERS3490766,SAMEA5686782 ERS3490766,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351573,ERS3490767,SAMEA5686783 ERS3490767,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351574,ERS3490768,SAMEA5686784 ERS3490768,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351575,ERS3490769,SAMEA5686785 ERS3490769,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351576,ERS3490770,SAMEA5686786 ERS3490770,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351577,ERS3490771,SAMEA5686787 ERS3490771,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351578,ERS3490772,SAMEA5686788 ERS3490772,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351579,ERS3490773,SAMEA5686789 ERS3490773,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351580,ERS3490774,SAMEA5686790 ERS3490774,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351581,ERS3490775,SAMEA5686791 ERS3490775,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351582,ERS3490776,SAMEA5686792 ERS3490776,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351583,ERS3490777,SAMEA5686793 ERS3490777,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351584,ERS3490778,SAMEA5686794 ERS3490778,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351585,ERS3490779,SAMEA5686795 ERS3490779,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351586,ERS3490780,SAMEA5686796 ERS3490780,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351587,ERS3490781,SAMEA5686797 ERS3490781,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351588,ERS3490782,SAMEA5686798 ERS3490782,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,Ghana,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351589,ERS3490783,SAMEA5686799 ERS3490783,06/01/2017,Single,"6.695070, -1.615800",Stool,,,Rural,,Kumasi,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351227,ERS3490421,SAMEA5686437 ERS3490421,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351228,ERS3490422,SAMEA5686438 ERS3490422,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351229,ERS3490423,SAMEA5686439 ERS3490423,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351231,ERS3490425,SAMEA5686441 ERS3490425,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351232,ERS3490426,SAMEA5686442 ERS3490426,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351233,ERS3490427,SAMEA5686443 ERS3490427,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351234,ERS3490428,SAMEA5686444 ERS3490428,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351235,ERS3490429,SAMEA5686445 ERS3490429,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351236,ERS3490430,SAMEA5686446 ERS3490430,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351237,ERS3490431,SAMEA5686447 ERS3490431,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351238,ERS3490432,SAMEA5686448 ERS3490432,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351239,ERS3490433,SAMEA5686449 ERS3490433,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351240,ERS3490434,SAMEA5686450 ERS3490434,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351241,ERS3490435,SAMEA5686451 ERS3490435,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351243,ERS3490437,SAMEA5686453 ERS3490437,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351246,ERS3490440,SAMEA5686456 ERS3490440,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351247,ERS3490441,SAMEA5686457 ERS3490441,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351249,ERS3490443,SAMEA5686459 ERS3490443,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351250,ERS3490444,SAMEA5686460 ERS3490444,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351251,ERS3490445,SAMEA5686461 ERS3490445,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351252,ERS3490446,SAMEA5686462 ERS3490446,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351253,ERS3490447,SAMEA5686463 ERS3490447,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351254,ERS3490448,SAMEA5686464 ERS3490448,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351255,ERS3490449,SAMEA5686465 ERS3490449,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351256,ERS3490450,SAMEA5686466 ERS3490450,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351257,ERS3490451,SAMEA5686467 ERS3490451,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351258,ERS3490452,SAMEA5686468 ERS3490452,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351259,ERS3490453,SAMEA5686469 ERS3490453,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351260,ERS3490454,SAMEA5686470 ERS3490454,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351261,ERS3490455,SAMEA5686471 ERS3490455,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351262,ERS3490456,SAMEA5686472 ERS3490456,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351263,ERS3490457,SAMEA5686473 ERS3490457,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351264,ERS3490458,SAMEA5686474 ERS3490458,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351265,ERS3490459,SAMEA5686475 ERS3490459,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351267,ERS3490461,SAMEA5686477 ERS3490461,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351268,ERS3490462,SAMEA5686478 ERS3490462,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351269,ERS3490463,SAMEA5686479 ERS3490463,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351270,ERS3490464,SAMEA5686480 ERS3490464,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351271,ERS3490465,SAMEA5686481 ERS3490465,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351272,ERS3490466,SAMEA5686482 ERS3490466,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351274,ERS3490468,SAMEA5686484 ERS3490468,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351276,ERS3490470,SAMEA5686486 ERS3490470,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351277,ERS3490471,SAMEA5686487 ERS3490471,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351278,ERS3490472,SAMEA5686488 ERS3490472,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351279,ERS3490473,SAMEA5686489 ERS3490473,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351280,ERS3490474,SAMEA5686490 ERS3490474,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351283,ERS3490477,SAMEA5686493 ERS3490477,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351284,ERS3490478,SAMEA5686494 ERS3490478,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351285,ERS3490479,SAMEA5686495 ERS3490479,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351286,ERS3490480,SAMEA5686496 ERS3490480,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351287,ERS3490481,SAMEA5686497 ERS3490481,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351288,ERS3490482,SAMEA5686498 ERS3490482,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351289,ERS3490483,SAMEA5686499 ERS3490483,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351290,ERS3490484,SAMEA5686500 ERS3490484,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351291,ERS3490485,SAMEA5686501 ERS3490485,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351292,ERS3490486,SAMEA5686502 ERS3490486,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351293,ERS3490487,SAMEA5686503 ERS3490487,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351294,ERS3490488,SAMEA5686504 ERS3490488,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351295,ERS3490489,SAMEA5686505 ERS3490489,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351296,ERS3490490,SAMEA5686506 ERS3490490,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351297,ERS3490491,SAMEA5686507 ERS3490491,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351298,ERS3490492,SAMEA5686508 ERS3490492,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351299,ERS3490493,SAMEA5686509 ERS3490493,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351300,ERS3490494,SAMEA5686510 ERS3490494,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351301,ERS3490495,SAMEA5686511 ERS3490495,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351302,ERS3490496,SAMEA5686512 ERS3490496,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351303,ERS3490497,SAMEA5686513 ERS3490497,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351304,ERS3490498,SAMEA5686514 ERS3490498,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351306,ERS3490500,SAMEA5686516 ERS3490500,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351307,ERS3490501,SAMEA5686517 ERS3490501,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351308,ERS3490502,SAMEA5686518 ERS3490502,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351309,ERS3490503,SAMEA5686519 ERS3490503,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351310,ERS3490504,SAMEA5686520 ERS3490504,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351311,ERS3490505,SAMEA5686521 ERS3490505,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351312,ERS3490506,SAMEA5686522 ERS3490506,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351313,ERS3490507,SAMEA5686523 ERS3490507,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351314,ERS3490508,SAMEA5686524 ERS3490508,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351315,ERS3490509,SAMEA5686525 ERS3490509,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351316,ERS3490510,SAMEA5686526 ERS3490510,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351317,ERS3490511,SAMEA5686527 ERS3490511,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351318,ERS3490512,SAMEA5686528 ERS3490512,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351319,ERS3490513,SAMEA5686529 ERS3490513,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351320,ERS3490514,SAMEA5686530 ERS3490514,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351321,ERS3490515,SAMEA5686531 ERS3490515,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351322,ERS3490516,SAMEA5686532 ERS3490516,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351338,ERS3490532,SAMEA5686548 ERS3490532,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351339,ERS3490533,SAMEA5686549 ERS3490533,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351340,ERS3490534,SAMEA5686550 ERS3490534,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351341,ERS3490535,SAMEA5686551 ERS3490535,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351342,ERS3490536,SAMEA5686552 ERS3490536,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351343,ERS3490537,SAMEA5686553 ERS3490537,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351344,ERS3490538,SAMEA5686554 ERS3490538,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351345,ERS3490539,SAMEA5686555 ERS3490539,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351346,ERS3490540,SAMEA5686556 ERS3490540,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351347,ERS3490541,SAMEA5686557 ERS3490541,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351348,ERS3490542,SAMEA5686558 ERS3490542,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351349,ERS3490543,SAMEA5686559 ERS3490543,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351350,ERS3490544,SAMEA5686560 ERS3490544,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351351,ERS3490545,SAMEA5686561 ERS3490545,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351352,ERS3490546,SAMEA5686562 ERS3490546,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351353,ERS3490547,SAMEA5686563 ERS3490547,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351354,ERS3490548,SAMEA5686564 ERS3490548,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351355,ERS3490549,SAMEA5686565 ERS3490549,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351356,ERS3490550,SAMEA5686566 ERS3490550,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351357,ERS3490551,SAMEA5686567 ERS3490551,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351358,ERS3490552,SAMEA5686568 ERS3490552,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351359,ERS3490553,SAMEA5686569 ERS3490553,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351360,ERS3490554,SAMEA5686570 ERS3490554,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351361,ERS3490555,SAMEA5686571 ERS3490555,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351362,ERS3490556,SAMEA5686572 ERS3490556,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351363,ERS3490557,SAMEA5686573 ERS3490557,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351364,ERS3490558,SAMEA5686574 ERS3490558,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351365,ERS3490559,SAMEA5686575 ERS3490559,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351366,ERS3490560,SAMEA5686576 ERS3490560,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351367,ERS3490561,SAMEA5686577 ERS3490561,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351368,ERS3490562,SAMEA5686578 ERS3490562,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351369,ERS3490563,SAMEA5686579 ERS3490563,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351370,ERS3490564,SAMEA5686580 ERS3490564,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351371,ERS3490565,SAMEA5686581 ERS3490565,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351372,ERS3490566,SAMEA5686582 ERS3490566,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351373,ERS3490567,SAMEA5686583 ERS3490567,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351374,ERS3490568,SAMEA5686584 ERS3490568,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351375,ERS3490569,SAMEA5686585 ERS3490569,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351376,ERS3490570,SAMEA5686586 ERS3490570,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351377,ERS3490571,SAMEA5686587 ERS3490571,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351378,ERS3490572,SAMEA5686588 ERS3490572,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351379,ERS3490573,SAMEA5686589 ERS3490573,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351380,ERS3490574,SAMEA5686590 ERS3490574,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351381,ERS3490575,SAMEA5686591 ERS3490575,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351382,ERS3490576,SAMEA5686592 ERS3490576,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351383,ERS3490577,SAMEA5686593 ERS3490577,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351384,ERS3490578,SAMEA5686594 ERS3490578,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351385,ERS3490579,SAMEA5686595 ERS3490579,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351386,ERS3490580,SAMEA5686596 ERS3490580,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351387,ERS3490581,SAMEA5686597 ERS3490581,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351388,ERS3490582,SAMEA5686598 ERS3490582,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351389,ERS3490583,SAMEA5686599 ERS3490583,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351390,ERS3490584,SAMEA5686600 ERS3490584,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351391,ERS3490585,SAMEA5686601 ERS3490585,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
PRJEB32880,PRJEB32880,337.0,"Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition : the METS-Microbiome study protocol // Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk",30081857 // 22168992,Amplicon,Illumina,South Africa,,,Cohort study,Gut,Illumina Miseq,partcipants aged from 25 to 45 years old,151.0,ERR3351392,ERS3490586,SAMEA5686602 ERS3490586,06/01/2017,Single,"-33.924870, 18.424055",Stool,,,Peri-urban,,Cape Town,v4,
